CN102495207B - High-sensitivity enzyme-linked immunoassay method - Google Patents
High-sensitivity enzyme-linked immunoassay method Download PDFInfo
- Publication number
- CN102495207B CN102495207B CN 201110439079 CN201110439079A CN102495207B CN 102495207 B CN102495207 B CN 102495207B CN 201110439079 CN201110439079 CN 201110439079 CN 201110439079 A CN201110439079 A CN 201110439079A CN 102495207 B CN102495207 B CN 102495207B
- Authority
- CN
- China
- Prior art keywords
- enzyme
- oscillation
- substrate
- antibody
- chemical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 56
- 238000002965 ELISA Methods 0.000 title claims abstract description 39
- 230000010355 oscillation Effects 0.000 claims abstract description 92
- 239000000126 substance Substances 0.000 claims abstract description 75
- 239000000758 substrate Substances 0.000 claims abstract description 57
- 238000001514 detection method Methods 0.000 claims abstract description 52
- 102000004190 Enzymes Human genes 0.000 claims abstract description 47
- 108090000790 Enzymes Proteins 0.000 claims abstract description 47
- 239000000427 antigen Substances 0.000 claims abstract description 35
- 102000036639 antigens Human genes 0.000 claims abstract description 32
- 108091007433 antigens Proteins 0.000 claims abstract description 32
- 239000012491 analyte Substances 0.000 claims abstract description 20
- 230000003321 amplification Effects 0.000 claims abstract description 13
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 13
- 238000002798 spectrophotometry method Methods 0.000 claims abstract description 11
- -1 antibodies Substances 0.000 claims abstract description 10
- 238000001179 sorption measurement Methods 0.000 claims abstract description 6
- 230000008569 process Effects 0.000 claims abstract description 5
- 229940088598 enzyme Drugs 0.000 claims description 46
- 238000006243 chemical reaction Methods 0.000 claims description 27
- 230000008859 change Effects 0.000 claims description 22
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 8
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 8
- 238000006555 catalytic reaction Methods 0.000 claims description 7
- 230000006698 induction Effects 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims description 6
- 238000005259 measurement Methods 0.000 claims description 6
- 229960002685 biotin Drugs 0.000 claims description 5
- 239000011616 biotin Substances 0.000 claims description 5
- 239000010949 copper Substances 0.000 claims description 5
- 238000003745 diagnosis Methods 0.000 claims description 5
- 230000001900 immune effect Effects 0.000 claims description 5
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical group OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 4
- 235000020958 biotin Nutrition 0.000 claims description 4
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 claims description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000001630 malic acid Substances 0.000 claims description 4
- 235000011090 malic acid Nutrition 0.000 claims description 4
- 241000894007 species Species 0.000 claims description 4
- 238000012360 testing method Methods 0.000 claims description 4
- 229910001428 transition metal ion Inorganic materials 0.000 claims description 4
- 108090001008 Avidin Proteins 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- 239000007795 chemical reaction product Substances 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 238000006911 enzymatic reaction Methods 0.000 claims description 3
- 229940074391 gallic acid Drugs 0.000 claims description 3
- 235000004515 gallic acid Nutrition 0.000 claims description 3
- CMPQUABWPXYYSH-UHFFFAOYSA-N phenyl phosphate Chemical group OP(O)(=O)OC1=CC=CC=C1 CMPQUABWPXYYSH-UHFFFAOYSA-N 0.000 claims description 3
- KUWPCJHYPSUOFW-YBXAARCKSA-N 2-nitrophenyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1[N+]([O-])=O KUWPCJHYPSUOFW-YBXAARCKSA-N 0.000 claims description 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 claims description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 claims description 2
- 102000015081 Blood Coagulation Factors Human genes 0.000 claims description 2
- 108010039209 Blood Coagulation Factors Proteins 0.000 claims description 2
- 239000004155 Chlorine dioxide Substances 0.000 claims description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 2
- 102000013460 Malate Dehydrogenase Human genes 0.000 claims description 2
- 108010026217 Malate Dehydrogenase Proteins 0.000 claims description 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 claims description 2
- 229930003268 Vitamin C Natural products 0.000 claims description 2
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 150000003863 ammonium salts Chemical class 0.000 claims description 2
- 102000005936 beta-Galactosidase Human genes 0.000 claims description 2
- 108010005774 beta-Galactosidase Proteins 0.000 claims description 2
- 239000003114 blood coagulation factor Substances 0.000 claims description 2
- 235000019398 chlorine dioxide Nutrition 0.000 claims description 2
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 claims description 2
- 235000019420 glucose oxidase Nutrition 0.000 claims description 2
- 239000000852 hydrogen donor Substances 0.000 claims description 2
- LNQCJIZJBYZCME-UHFFFAOYSA-N iron(2+);1,10-phenanthroline Chemical compound [Fe+2].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 LNQCJIZJBYZCME-UHFFFAOYSA-N 0.000 claims description 2
- 239000004310 lactic acid Substances 0.000 claims description 2
- 235000014655 lactic acid Nutrition 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 2
- 239000011976 maleic acid Substances 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 2
- 150000002894 organic compounds Chemical class 0.000 claims description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 claims description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 2
- 235000019154 vitamin C Nutrition 0.000 claims description 2
- 239000011718 vitamin C Substances 0.000 claims description 2
- 238000010521 absorption reaction Methods 0.000 claims 3
- 229910019142 PO4 Inorganic materials 0.000 claims 2
- 239000010452 phosphate Substances 0.000 claims 2
- WHJMGMTWMIGGQF-UHFFFAOYSA-N 1,1'-biphenyl;methanamine Chemical group NC.C1=CC=CC=C1C1=CC=CC=C1 WHJMGMTWMIGGQF-UHFFFAOYSA-N 0.000 claims 1
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 claims 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 claims 1
- 108090000854 Oxidoreductases Proteins 0.000 claims 1
- 102000004316 Oxidoreductases Human genes 0.000 claims 1
- 229960004909 aminosalicylic acid Drugs 0.000 claims 1
- DMVOXQPQNTYEKQ-UHFFFAOYSA-N biphenyl-4-amine Chemical compound C1=CC(N)=CC=C1C1=CC=CC=C1 DMVOXQPQNTYEKQ-UHFFFAOYSA-N 0.000 claims 1
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Chemical compound CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 238000000691 measurement method Methods 0.000 claims 1
- 230000033116 oxidation-reduction process Effects 0.000 claims 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims 1
- 229940095064 tartrate Drugs 0.000 claims 1
- CBDKQYKMCICBOF-UHFFFAOYSA-N thiazoline Chemical compound C1CN=CS1 CBDKQYKMCICBOF-UHFFFAOYSA-N 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 14
- 201000010099 disease Diseases 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 230000027455 binding Effects 0.000 abstract description 6
- 230000003197 catalytic effect Effects 0.000 abstract description 5
- 238000012933 kinetic analysis Methods 0.000 abstract description 5
- 108090000623 proteins and genes Proteins 0.000 abstract description 4
- 230000009870 specific binding Effects 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 3
- 150000003384 small molecules Chemical class 0.000 abstract description 3
- 102000039446 nucleic acids Human genes 0.000 abstract description 2
- 108020004707 nucleic acids Proteins 0.000 abstract description 2
- 150000007523 nucleic acids Chemical class 0.000 abstract description 2
- 239000000575 pesticide Substances 0.000 abstract description 2
- 102000004169 proteins and genes Human genes 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 8
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 5
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 5
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 description 4
- 239000005660 Abamectin Substances 0.000 description 4
- 230000005526 G1 to G0 transition Effects 0.000 description 4
- 241000711549 Hepacivirus C Species 0.000 description 4
- MIJPAVRNWPDMOR-UHFFFAOYSA-N [2-(1,2-dihydroxyethyl)-3-hydroxy-5-oxo-2h-furan-4-yl] dihydrogen phosphate Chemical compound OCC(O)C1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-UHFFFAOYSA-N 0.000 description 4
- 229950008167 abamectin Drugs 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 230000000737 periodic effect Effects 0.000 description 4
- 239000007790 solid phase Substances 0.000 description 4
- 108010090804 Streptavidin Proteins 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 239000003547 immunosorbent Substances 0.000 description 3
- 239000013067 intermediate product Substances 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 2
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- HOLGXWDGCVTMTB-UHFFFAOYSA-N 2-(2-aminophenyl)aniline Chemical compound NC1=CC=CC=C1C1=CC=CC=C1N HOLGXWDGCVTMTB-UHFFFAOYSA-N 0.000 description 1
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 229910020366 ClO 4 Inorganic materials 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- IOMLBTHPCVDRHM-UHFFFAOYSA-N [3-[(2,4-dimethylphenyl)carbamoyl]naphthalen-2-yl] dihydrogen phosphate Chemical compound CC1=CC(C)=CC=C1NC(=O)C1=CC2=CC=CC=C2C=C1OP(O)(O)=O IOMLBTHPCVDRHM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 150000001615 biotins Chemical class 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- 150000001989 diazonium salts Chemical class 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 230000036046 immunoreaction Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000447 pesticide residue Substances 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- CRWJEUDFKNYSBX-UHFFFAOYSA-N sodium;hypobromite Chemical compound [Na+].Br[O-] CRWJEUDFKNYSBX-UHFFFAOYSA-N 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229910052716 thallium Inorganic materials 0.000 description 1
- BKVIYDNLLOSFOA-UHFFFAOYSA-N thallium Chemical compound [Tl] BKVIYDNLLOSFOA-UHFFFAOYSA-N 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
一种基于化学振荡动力学检测的酶联免疫分析方法,该方法根据被测物与抗体(抗原)特异性结合的特性,在特定条件下,以相应的酶标记抗原或抗体与对应的抗体或抗原完成吸附结合过程,它利用标记的酶对底物的催化速度来间接表示被测物的浓度。本方法既有效地克服了基于分光光度法的常规酶联免疫法敏感度不足的问题,又利用了抗体-抗原特异性结合的原理,将高灵敏度的化学振荡动力学检测和具有专一性和灵敏度放大作用的酶催化动力学分析结合起来,克服了化学振荡选择性低、不能进行定性测定的问题,使结合了酶联免疫法的化学振荡可以定性定量测定医药及农药小分子、抗体、抗原、特定蛋白质、核酸、疾病因子等物质。
An enzyme-linked immunoassay method based on chemical oscillation kinetic detection. According to the specific binding characteristics of the analyte and antibody (antigen), under specific conditions, the corresponding enzyme-labeled antigen or antibody and the corresponding antibody or The antigen completes the process of adsorption and binding, which uses the catalytic speed of the labeled enzyme to the substrate to indirectly represent the concentration of the analyte. This method not only effectively overcomes the problem of insufficient sensitivity of conventional ELISA based on spectrophotometry, but also utilizes the principle of antibody-antigen specific binding to combine high-sensitivity chemical oscillation kinetic detection with specificity and The combination of enzyme-catalyzed kinetic analysis with sensitivity amplification overcomes the problems of low selectivity of chemical oscillation and incapability of qualitative determination, so that chemical oscillation combined with enzyme-linked immunoassay can qualitatively and quantitatively determine small molecules of medicine and pesticides, antibodies, antigens , specific proteins, nucleic acids, disease factors and other substances.
Description
技术领域 technical field
本发明涉及一种基于化学振荡动力学检测底物变化的高灵敏度酶联免疫吸附分析方法,属生物化学分析方法技术领域。 The invention relates to a high-sensitivity enzyme-linked immunosorbent assay method for detecting substrate changes based on chemical oscillation dynamics, belonging to the technical field of biochemical analysis methods.
背景技术Background technique
酶联免疫测定法自Engvall于1971年创立以来,以其简便、快速、无放射性等特点获得了超速发展,现已广泛地运用于生物医学研究及临床疾病诊断等领域。很多重要的疾病诊断标志物采用了酶联免疫测定,如测抗HAV、乙肝五项、抗HCV,抗HIV,梅毒抗体、优生优育TORCH系列、性病病原体的抗原或抗体、激素、肿瘤标志物、自身抗体、细胞因子、H BV-DNA、HCV-RNA、遗传病基因以及肿瘤基因等。酶联免疫测定为疾病早期发现、疾病诊断,治疗方案制定、疗效评价、以及血液检测等提供了性命攸关的实验数据。酶联免疫测定法在农药残留、药物检测、低浓度化学品分析上也得到了广泛应用。 Since its founding by Engvall in 1971, enzyme-linked immunoassay (ELISA) has achieved rapid development due to its simplicity, rapidity, and non-radioactivity, and has been widely used in biomedical research and clinical disease diagnosis. Many important disease diagnostic markers use enzyme-linked immunoassays, such as anti-HAV, hepatitis B five items, anti-HCV, anti-HIV, syphilis antibodies, prenatal and postnatal TORCH series, antigens or antibodies of venereal pathogens, hormones, tumor markers, Autoantibodies, cytokines, HBV-DNA, HCV-RNA, genetic disease genes and tumor genes, etc. Enzyme-linked immunoassay provides life-critical experimental data for early detection of diseases, disease diagnosis, treatment plan formulation, curative effect evaluation, and blood testing. ELISA has also been widely used in pesticide residues, drug detection, and low-concentration chemical analysis.
经典的酶联免疫吸附分析法原理为,被测物通过抗原-抗体系统特异性地吸附活性酶;酶催化底物进行水解或氧化还原反应并导致底物吸光度的变化;利用酶标仪在特定波长下检测底物吸光度的变化值。在理想的双夹心法或间接法定量检测中,在特定反应条件下,在一定浓度范围内,吸光度的变化值与交联在抗原或抗体上酶的物质的量成近似正比,即与被检测的抗原或抗体浓度近似成正比。对于定性检测,可以通过统计方法确认诊断结果的截断值。因酶标仪是以分光光度法为检测基础的,分光光度法对底物的最低检测限一般高于10-5mol/L,即使考虑到酶促反应数以千倍的放大作用,其检测限也远高于免疫放射法的检测限,即:只有高浓度的抗原或抗体才能被常规的酶联免疫测定法所检测。因分光光度法对底物检测方法的局限性,低浓度的诊断标志物用经典的酶联免疫测定法测不了或测不准,这也在一定程度上降低了常规酶联免疫法在疾病诊断中的敏感度和适用范围。 The principle of the classic enzyme-linked immunosorbent assay method is that the analyte specifically adsorbs the active enzyme through the antigen-antibody system; the enzyme catalyzes the hydrolysis or redox reaction of the substrate and causes a change in the absorbance of the substrate; The change value of the absorbance of the substrate is detected at the wavelength. In an ideal double-sandwich method or indirect method quantitative detection, under specific reaction conditions, within a certain concentration range, the change value of absorbance is approximately proportional to the amount of the enzyme cross-linked on the antigen or antibody, that is, the is approximately proportional to the antigen or antibody concentration. For qualitative testing, the cut-off values for diagnostic results can be confirmed by statistical methods. Because the microplate reader is based on spectrophotometry, the minimum detection limit of the substrate is generally higher than 10 -5 mol/L by spectrophotometry. The detection limit is also much higher than that of the immunoradiological assay, that is, only high concentrations of antigens or antibodies can be detected by conventional enzyme-linked immunoassays. Due to the limitations of spectrophotometry on substrate detection methods, low-concentration diagnostic markers cannot be detected or accurately detected by classical enzyme-linked immunoassays, which also reduces the effectiveness of conventional enzyme-linked immunoassays in disease diagnosis to a certain extent. Sensitivity and scope of application.
化学振荡是指在远离平衡态的开放化学反应体系中,中间物浓度在时间和空间上呈现有规律的周期性变化。化学振荡吸引了人们从理论和应用两个层面研究这一非线性化学现象。在理论方面,比利时物理化学家伊里亚•普里高津创立了耗散结构理论,解释了一个系统从混沌无序向有序转化的机理、条件和规律。在应用层面,运用化学振荡动力学分析法成功地进行了一系列有机物和无机物的检测。在化学振荡中,因化学反应和扩散的复杂性,某些物理量如中间产物浓度、电极电势等会随时间而周期性地变化,特定微量外加物的存在将影响振荡反应并产生相关的特征信号。1978年Tikhonova将在封闭体系中的经典化学振荡器用于Ru2+检测,通过对振荡过程中电极电势随时间变化的动力学曲线分析,建立了化学振荡动力学检测法。与传统比较,该方法具有简便快速、灵敏度高等优点。已测定了铊、汞、银离子,维生素K3、B2、B6,也有用于CO、Cl2、ClO2等气体浓度的报导。因在封闭体系中的经典的以金属离子为催化剂的化学振荡不稳定,导致测定相对误差较大,1995年Rafael提出,将封闭体系改为在连续流动搅拌反应器中,利用分析物脉冲微扰技术,向远离平衡态的振荡体系中以脉冲的方式注入不同 浓度的被分析物种,观察振荡反应体系的特征信号的变化并与标准特征信号相比较,就能发现被分析物种浓度与特征信号的变化量之间的关系。目前这种方法已测定了没食子酸、咖啡因、柑桔汁中的维生素C、糖中的香蓝醛等。运用分析物脉冲微扰技术梁菊对过氧亚硝酸阴离子检测限达到2.25×10-9mol/L,Guo对糠醛的检测限达到3×10− 9 mol L− 11。尽管化学振荡检测灵敏度非常之高,但化学振荡检测法对多种外加物非常敏感,选择性差,故化学振荡检测法多用于定量检测而非定性检测。 Chemical oscillation refers to the regular periodic changes in the concentration of intermediates in time and space in an open chemical reaction system far from the equilibrium state. Chemical oscillations have attracted people to study this nonlinear chemical phenomenon from both theoretical and applied levels. In terms of theory, Belgian physical chemist Ilya Prigogine created the theory of dissipative structure, which explained the mechanism, conditions and laws of a system transforming from chaos to order. At the application level, a series of organic and inorganic substances have been successfully detected by using the chemical oscillation kinetic analysis method. In chemical oscillation, due to the complexity of chemical reaction and diffusion, certain physical quantities such as intermediate product concentration, electrode potential, etc. will change periodically with time, and the existence of specific trace additives will affect the oscillation reaction and generate related characteristic signals . In 1978, Tikhonova used a classical chemical oscillator in a closed system for Ru 2+ detection, and established a chemical oscillation kinetic detection method by analyzing the kinetic curve of the electrode potential changing with time during the oscillation process. Compared with the traditional method, this method has the advantages of simplicity, rapidity and high sensitivity. Thallium, mercury, silver ions, vitamin K 3 , B 2 , B 6 have been measured, and there are also reports for the concentration of CO, Cl 2 , ClO 2 and other gases. Due to the instability of the classic chemical oscillation with metal ions as the catalyst in the closed system, the relative error of the measurement is relatively large. In 1995, Rafael proposed to change the closed system to a continuous flow stirred reactor, using analyte pulse perturbation Technology, inject different concentrations of analyte species into the oscillation system far away from the equilibrium state in a pulsed manner, observe the change of the characteristic signal of the oscillation reaction system and compare it with the standard characteristic signal, you can find the difference between the concentration of the analyte species and the characteristic signal relationship between variables. At present, this method has been used to determine gallic acid, caffeine, vitamin C in citrus juice, and cylanaldehyde in sugar. Using the analyte pulse perturbation technique, Liang Ju's detection limit for peroxynitrite anion was 2.25×10 -9 mol/L, and Guo's detection limit for furfural was 3×10 − 9 mol L − 11 . Although the sensitivity of chemical oscillation detection is very high, the chemical oscillation detection method is very sensitive to various admixtures and has poor selectivity, so the chemical oscillation detection method is mostly used for quantitative detection rather than qualitative detection.
发明内容Contents of the invention
本发明的目的是,为克服基于分光光度法的常规酶联免疫法敏感度不足的问题,用一种新的高灵敏的检测底物变化的方法代替分光光度法可以大幅度的提高分析灵敏度;因单纯的化学振荡法选择性低,无法进行定性检测,如果将高灵敏度的化学振荡动力学检测和具有专一性和灵敏度放大作用的酶催化动力学分析结合起来,将能克服化学振荡选择性低、不能进行定性测定的问题。 The object of the present invention is, in order to overcome the insufficient sensitivity of conventional ELISA based on spectrophotometry, replace spectrophotometry with a new highly sensitive method for detecting substrate changes, which can greatly improve the analytical sensitivity; Due to the low selectivity of the simple chemical oscillation method, qualitative detection cannot be performed. If the high-sensitivity chemical oscillation kinetic detection and the enzyme-catalyzed kinetic analysis with specificity and sensitivity amplification are combined, the chemical oscillation selectivity will be overcome. Low, can not be qualitatively measured.
本发明的技术方案是,本发明将高频化学振荡动力学检测引入酶联免疫检测系统,将高灵敏度的化学振荡检测和高度特异性的酶联免疫诊断技术巧妙地结合起来,以化学振荡法代替分光光度法,检测酶联免疫分析中底物及其产物浓度的变化,从而建立基于化学振荡动力学检测的酶联免疫诊断技术。 The technical solution of the present invention is that the present invention introduces high-frequency chemical oscillation kinetic detection into the ELISA detection system, skillfully combines high-sensitivity chemical oscillation detection and highly specific ELISA diagnostic technology, and uses chemical oscillation method Instead of spectrophotometry, detect changes in the concentration of substrates and their products in enzyme-linked immunoassays, thereby establishing an enzyme-linked immunological diagnostic technology based on chemical oscillation kinetic detection.
本发明根据被测物与抗体(抗原)特异性结合的特性,在一定温度和时间内,以相应的酶标记抗原或抗体与对应的抗体或抗原完成吸附结合过程,它利用标记的酶对底物的催化速度来间接表示被测物的浓度,而底物或底物的酶促反应产物浓度的检测手段为化学振荡动力学检测法。基于化学振荡动力学检测的酶联免疫分析技术的定性测定原理为,只有存在被测物时,被测定物将酶联免疫特异性与对应抗体(抗原)结合,特定抗体或抗原将被吸附,其直接或间接联结的酶将会被吸附,在一定的温度和时间内催化底物反应,当变化的底物加入到化学反应振荡体系中时,底物的变化将引起化学振荡特征值如周期、振幅、中间物产物浓度、诱导期等变化。与空白对比,化学振荡特征值的改变将反映出是否存在被测定物。基于化学振荡动力学检测的酶联免疫分析技术的定量测定原理为,被测物浓度的变化将引起直接或间接与被测物结合的特异性抗体(抗原)结合量的相应改变,其直接或间接联结酶的量将会随之改变,对底物的催化反应速度将产生对应变化,当底物加入到化学反应振荡体系中时,化学振荡特征值如周期、振幅、中间物产物浓度、诱导期的改变将反映出底物及产物浓度的变化。 According to the characteristics of the specific binding between the test object and the antibody (antigen), the present invention uses the corresponding enzyme to label the antigen or antibody and the corresponding antibody or antigen to complete the adsorption and binding process at a certain temperature and time. The concentration of the analyte can be indirectly expressed by the catalytic speed of the substance, and the detection method of the concentration of the substrate or the enzymatic reaction product of the substrate is a chemical oscillation kinetic detection method. The qualitative determination principle of the enzyme-linked immunoassay technology based on chemical oscillation kinetic detection is that only when the analyte exists, the analyte will specifically bind the ELISA to the corresponding antibody (antigen), and the specific antibody or antigen will be adsorbed. The directly or indirectly linked enzyme will be adsorbed and catalyze the substrate reaction at a certain temperature and time. When the changed substrate is added to the chemical reaction oscillation system, the change of the substrate will cause the chemical oscillation characteristic value such as period , amplitude, intermediate product concentration, induction period and other changes. Compared with the blank, the change of the chemical oscillation characteristic value will reflect the presence or absence of the analyte. The principle of quantitative determination of enzyme-linked immunoassay technology based on chemical oscillation kinetic detection is that changes in the concentration of the analyte will cause a corresponding change in the binding amount of specific antibodies (antigens) that directly or indirectly bind to the analyte, which directly or indirectly The amount of the indirect link enzyme will change accordingly, and the catalytic reaction speed of the substrate will have a corresponding change. When the substrate is added to the chemical reaction oscillation system, the chemical oscillation characteristic values such as period, amplitude, intermediate product concentration, induction Changes in the period will reflect changes in substrate and product concentrations.
本发明还利用了抗体-抗原特异性结合的原理,将高灵敏度的化学振荡动力学检测和具有专一性和灵敏度放大作用的酶催化动力学分析结合起来,让化学振荡检测只检测被测定物,避免了其它杂质的干扰,克服了化学振荡选择性低、不能进行定性测定的问题,使化学振荡可以进行定性定量测定。有效选择的酶联免疫的酶、底物、以及化学振荡反应体系可以大幅度提高酶联免疫检测的灵敏度。 The present invention also utilizes the principle of antibody-antigen specific combination, and combines high-sensitivity chemical oscillation kinetic detection with enzyme-catalyzed kinetic analysis with specificity and sensitivity amplification, so that chemical oscillation detection can only detect the analyte , to avoid the interference of other impurities, to overcome the low selectivity of chemical oscillation, the problem of qualitative determination cannot be carried out, so that chemical oscillation can be used for qualitative and quantitative determination. Effective selection of ELISA enzymes, substrates, and chemical oscillation reaction systems can greatly improve the sensitivity of ELISA detection.
本发明所述的酶联免疫吸附吸附法可以是间接法、双抗体夹心法、双位点一步法、竞争法、捕获法,生物素-亲和素法。 The ELISA method of the present invention may be an indirect method, a double-antibody sandwich method, a two-site one-step method, a competition method, a capture method, or a biotin-avidin method.
本发明所述的酶联免疫吸附吸附法中酶的检测体系可以是: A, 双氧水/辣根过氧化物酶体系,对应供氢体为邻苯二胺,四甲替联苯胺,氨基水杨酸,邻联苯甲胺,2,2-连胺基-2(3-乙基-并噻唑啉磺酸-6)铵盐;B,碱性磷酸酯酶体系,底物为苯酚磷酸盐、维生素C磷酸酯、4-硝基酚磷酸盐酯(PNP) 或萘酚-AS-Mx磷酸盐+重氮盐 ;C,β-D-半乳糖苷酶体系,底物为4MuG或ONPG;D,苹果酸脱氢酶体系,底物为苹果酸,E葡萄糖氧化酶体系。 The enzyme detection system in the enzyme-linked immunosorbent adsorption method of the present invention can be: A, hydrogen peroxide/horseradish peroxidase system, the corresponding hydrogen donors are o-phenylenediamine, tetramethylbenzidine, aminosalicyl Acid, o-benzidine, 2,2-amino-2 (3-ethyl-thiazolinesulfonic acid-6) ammonium salt; B, alkaline phosphatase system, the substrate is phenol phosphate, Vitamin C phosphate, 4-nitrophenol phosphate (PNP) or naphthol-AS-Mx phosphate + diazonium salt; C, β-D-galactosidase system, the substrate is 4MuG or ONPG; D , Malate dehydrogenase system, the substrate is malic acid, E glucose oxidase system.
本发明所述的酶联免疫吸附吸附法中酶的检测体系也可以是采用多酶级联放大系统代替单一的辣根过氧化酶或碱性磷酸酶系统,以提高酶对最终底物的催化反应能力,如生物素(结构改造的生物素)和亲和素(结构改造的亲和素)系统, AP及醇脱氢酶、黄递酶组成酶级联底物放大系统,酶抑制级联放大系统,凝固因子酶级联放大系统。 The enzyme detection system in the enzyme-linked immunosorbent adsorption method of the present invention can also be a multi-enzyme cascade amplification system instead of a single horseradish peroxidase or alkaline phosphatase system, so as to improve the catalysis of the enzyme to the final substrate. Response capabilities, such as biotin (structurally modified biotin) and avidin (structurally modified avidin) systems, AP, alcohol dehydrogenase, and diaphorase constitute an enzyme cascade substrate amplification system, and enzyme inhibition cascade amplification System, coagulation factor enzyme cascade amplification system.
本发明所涉及的化学振荡为B-Z振荡反应,B-L振荡体系,B-R振荡反应,铜催化振荡反应,二氧化氯化学振荡反应,过氧化酶–氧化酶生化振荡体系,高锰酸盐振荡反应,液膜振荡反应体系。 The chemical oscillation involved in the present invention is B-Z oscillation reaction, B-L oscillation system, B-R oscillation reaction, copper catalyzed oscillation reaction, chlorine dioxide chemical oscillation reaction, peroxidase-oxidase biochemical oscillation system, permanganate oscillation reaction, liquid Membrane oscillation reaction system.
在铜催化的B-Z振荡体系、B-L振荡体系、B-R振荡反应中,底物可以是氧化还原电极电势在1.0 V以下,具有活性亚甲基的多氧有机化合物,如丙二酸、酒石酸、没食子酸、焦性没食子酸、乳酸、丙酮、马来酸、柠檬酸、苹果酸、乙酰丙酮、乙酰乙酸乙酯等。 In the copper-catalyzed B-Z oscillation system, B-L oscillation system, and B-R oscillation reaction, the substrate can be a polyoxygen organic compound with an active methylene group, such as malonic acid, tartaric acid, and gallic acid, with a redox electrode potential below 1.0 V. , Pyrogallic acid, lactic acid, acetone, maleic acid, citric acid, malic acid, acetylacetone, ethyl acetoacetate, etc.
在本发明化学振荡反应中的催化剂可以是M(n+l)+/ Mn +电极电位在1.00-1.51V之间的过渡金属离子或过渡金属离子配合物,如Ce3+/Ce4+(1.44V),Mn2+/Mn3+(1.44V), Ru(bpy)2 2+/ Ru(bpy)3 3+,Fe(phen)2 2+/Fe(phen)3 3+ 以及 Cu2+ 、Ni 2+与四氮大环配合物。 The catalyst in the chemical oscillation reaction of the present invention can be a transition metal ion or a transition metal ion complex with M (n+l)+ /M n + electrode potential between 1.00-1.51V, such as Ce 3+ /Ce 4+ (1.44V), Mn 2+ /Mn 3+ (1.44V), Ru(bpy) 2 2+ / Ru(bpy) 3 3+ , Fe(phen) 2 2+ /Fe(phen) 3 3+ and Cu 2+ , Ni 2+ and tetrazamacrocyclic complexes.
化学振荡的测定体系可以是封闭体系;可以是连续流动搅拌的开放体系,它利用分析物脉冲微扰技术,向远离平衡态的振荡体系中以脉冲的方式注入不同浓度的被分析物种;也可以利用分岔前所处的亚临界状态体系进行测定。 The measurement system of chemical oscillation can be a closed system; it can be an open system with continuous flow stirring, which uses the analyte pulse perturbation technology to inject different concentrations of analyte species into the oscillation system far away from the equilibrium state in a pulsed manner; it can also be Use the subcritical state system before the bifurcation for determination.
化学振荡特点的测定指标可以是诱导期的改变、加入底物前后电位的改变或加入底物前后的振荡周期的改变。 The measurement index of the chemical oscillation characteristic can be the change of the induction period, the change of the potential before and after the addition of the substrate, or the change of the oscillation period before and after the addition of the substrate.
图1为基于化学振荡检测底物的酶联免疫吸附分析法的原理示意图,它以最经典的抗体-抗原-抗体三明冶夹心法为例,说明本发明检测方法的原理。如图所示,将具有专一性之抗体固着于固定相上,为固定相抗体1,完成後洗去多馀抗体;加入待测物标本2,标本中若含有待测之抗原,则会与固定相上的抗体进行专一性结合;洗去待测标本非结合部分,加入标记有酶5之二次抗体3,与抗原结合; 洗去多余未结合的二次抗体,加入可以被酶催化的底物6,在一定的时间内,标记在二次抗体上的酶4将对底物进行催化,形成催化产物7。将酶催化产生的底物注射到一个化学振荡反应体系中,测定比较该振荡体系的周期、振幅或诱导期的变化,与标准周期、振幅或诱导期比较,计算并检定抗原浓度。在一定温度和时间内,以相应的酶标记抗原或抗体与对应的抗体或抗原完成吸附结合过程,它利用标记的酶对底物的催化速度来间接表示诊断标志物的浓度,而底物或酶促反应产物浓度的检测手段为化学振荡动力学检测法。
Figure 1 is a schematic diagram of the principle of the enzyme-linked immunosorbent assay method based on chemical oscillation detection of substrates. It takes the most classic antibody-antigen-antibody sandwich method as an example to illustrate the principle of the detection method of the present invention. As shown in the figure, the specific antibody is immobilized on the stationary phase, which is the stationary phase antibody 1. After the completion, the excess antibody is washed away; the specimen to be tested is added to the specimen 2. If the specimen contains the antigen to be tested, it will be Combine specifically with the antibody on the stationary phase; wash away the non-binding part of the sample to be tested, add secondary antibody 3 labeled with enzyme 5, and bind to the antigen; wash away excess unbound secondary antibody, add For the catalyzed
本发明与现有技术比较的有益效果是,本发明将高频化学振荡动力学检测引入酶联免疫检测系统,将高灵敏度的化学振荡检测和高度特异性的酶联免疫诊断技术巧妙地结合起来,以化学振荡法代替分光光度法,检测酶联免疫分析中底物及其产物浓度的变化,从而建立基于化学振荡动力学检测的酶联免疫诊断技术。本方法既有效的克服了基于分光光度法的常规酶联免疫法敏感度不足的问题,用一种新的高灵敏的检测底物变化的方法代替分光光度法可以大幅度的提高分析灵敏度;在另一方面,本发明又利用了抗体-抗原特异性结合的原理,将高灵敏度的化学振荡动力学检测和具有专一性和灵敏度放大作用的酶催化动力学分析结合起来,让化学振荡检测只检测被测定物,避免了其它杂质的干扰,克服了化学振荡选择性低、不能进行定性测定的问题,使化学振荡可以进行定性定量测定。有效选择的酶联免疫的酶、底物、以及化学振荡反应体系可以大幅度提高酶联免疫检测的灵敏度。 The beneficial effect of the present invention compared with the prior art is that the present invention introduces high-frequency chemical oscillation dynamic detection into the enzyme-linked immunosorbent detection system, and skillfully combines high-sensitivity chemical oscillation detection and highly specific enzyme-linked immunological diagnostic technology , using the chemical oscillation method instead of the spectrophotometric method to detect the changes in the concentration of the substrate and its products in the enzyme-linked immunoassay, thereby establishing an enzyme-linked immunological diagnostic technology based on the detection of chemical oscillation kinetics. This method not only effectively overcomes the problem of insufficient sensitivity of the conventional enzyme-linked immunosorbent assay based on spectrophotometry, but also can greatly improve the analytical sensitivity by replacing the spectrophotometric method with a new highly sensitive method for detecting substrate changes; On the other hand, the present invention utilizes the principle of antibody-antigen specific binding, and combines high-sensitivity chemical oscillation kinetic detection with enzyme-catalyzed kinetic analysis with specificity and sensitivity amplification, so that chemical oscillation detection only Detecting the analyte avoids the interference of other impurities, overcomes the problem of low selectivity of chemical oscillation and cannot perform qualitative determination, and enables qualitative and quantitative determination of chemical oscillation. Effective selection of ELISA enzymes, substrates, and chemical oscillation reaction systems can greatly improve the sensitivity of ELISA detection.
本发明适用于定性定量测定医药及农药小分子、抗体、抗原、特定蛋白质、核酸、疾病因子等物质。 The invention is suitable for qualitative and quantitative determination of small molecules of medicine and pesticides, antibodies, antigens, specific proteins, nucleic acids, disease factors and other substances.
附图说明 Description of drawings
图1为基于化学振荡检测底物的酶联免疫吸附分析法的原理示意图; 1 is a schematic diagram of the principle of an enzyme-linked immunosorbent assay method based on chemical oscillation detection of a substrate;
图中图号表示:1是固定相抗体;2是待测物;3是酶联抗体;4是联在抗体上的酶;5是酶;6是底物;7是酶催化产物。 The numbers in the figure indicate: 1 is the stationary phase antibody; 2 is the analyte; 3 is the enzyme-linked antibody; 4 is the enzyme linked to the antibody; 5 is the enzyme; 6 is the substrate; 7 is the product catalyzed by the enzyme.
具体实施方式 Detailed ways
实施例1 Example 1
本实施例采用间接法测定丙型肝炎病毒(HCV)抗体:将病原体的抗原包被,形成固相抗原,处理后加入可能含丙型肝炎病毒(HCV)待测抗体的临床样本如血清样品等,温育,洗板,加入辣根过氧化物酶标记的抗人IgG抗体,温育,洗板;加入酶底物双氧水,温育,用B-Z(Belousov-Zhabotinsky)化学振荡动力学检测酶促产物与原底物之间差异。B-Z体系中以十四员四氮杂大环(Curtis环)的铜(Ⅱ)配合物为催化剂,以NaBrO4-苹果酸-[CuL](ClO4)2-H2SO4为化学振荡体系,在摄氏22 度形成稳定振荡体系,将催化产物加入本体系,根据化学振荡所引起的周期的变化,间接确认抗体存在与否。 This embodiment uses an indirect method to measure hepatitis C virus (HCV) antibody: the antigen of the pathogen is coated to form a solid-phase antigen, and after treatment, clinical samples that may contain hepatitis C virus (HCV) antibody to be tested, such as serum samples, are added. , incubate, wash the plate, add horseradish peroxidase-labeled anti-human IgG antibody, incubate, wash the plate; add enzyme substrate hydrogen peroxide, incubate, use BZ (Belousov-Zhabotinsky) chemical oscillation kinetics to detect enzymatic activity The difference between the product and the original substrate. In the BZ system, the copper (Ⅱ) complex of fourteen-membered tetraazamacrocycle (Curtis ring) is used as the catalyst, and NaBrO 4 -malic acid-[CuL](ClO 4 ) 2 -H 2 SO 4 is used as the chemical oscillation system , form a stable oscillation system at 22 degrees Celsius, add catalytic products to this system, and indirectly confirm the presence or absence of antibodies according to the periodic changes caused by chemical oscillations.
实施例2 Example 2
本实施例采用双抗体夹心法测定乙肝病毒e抗原(HBeAg):将HBeAg抗体吸附于固相表面; 加待测抗原样品,温育,洗板,形成抗原-抗体复合物,加用碱性磷酸酯酶ALP酶标的抗人Ig抗体,形成抗体-抗原-抗体三明冶夹心结构,加可以被酶水解催化的底物磷酸维生素C,在37度时温育30分钟,加入至流动的化学振荡体系,底物磷酸维生素C本身不会引起振荡体系的周期、振幅或诱导期变化改变,但底物磷酸维生素C可以引起振荡体系的周期变化,计算抗原浓度或确认抗原存在与否。 In this example, the double-antibody sandwich method is used to determine hepatitis B virus e antigen (HBeAg): the HBeAg antibody is adsorbed on the solid phase surface; the antigen sample to be tested is added, incubated, and the plate is washed to form an antigen-antibody complex, and alkaline phosphoric acid is added Esterase ALP enzyme-labeled anti-human Ig antibody forms an antibody-antigen-antibody sandwich structure, adds vitamin C phosphate, a substrate that can be catalyzed by enzyme hydrolysis, incubates at 37 degrees for 30 minutes, and adds it to the flowing chemical oscillation system , the substrate vitamin C phosphate itself will not cause changes in the period, amplitude or induction period of the oscillation system, but the substrate vitamin C phosphate can cause periodic changes in the oscillation system to calculate the concentration of antigen or confirm the presence or absence of antigen.
实施例3 Example 3
本实施例采用竞争法测定小分子半抗原阿维菌素:将阿维菌素抗体吸附在固相载体表面,加入辣根过氧化物酶的标记的酶标抗原和待测阿维菌素样品,竞争结合抗体;对照只加入酶标抗原,加底物双氧水。温育30分钟后将生成物加入到化学振荡体系[Ni(LA3)]2+,丙二酸,H3P04中,测定两振荡体系的振幅变化,并与标准的,仅加抗原的振幅变化值进行比较,计算抗原阿维菌素浓度,本方法最低检测限可达2.1*10-8mol/L。 In this example, a competitive method is used to determine the small molecule hapten abamectin: the abamectin antibody is adsorbed on the surface of a solid phase carrier, and the enzyme-labeled antigen labeled with horseradish peroxidase and the abamectin sample to be tested are added , to compete for binding antibodies; for the control, only enzyme-labeled antigen was added, and substrate hydrogen peroxide was added. After incubating for 30 minutes, the product was added to the chemical shaking system [Ni(LA3)] 2+ , malonic acid, H 3 P0 4 , and the amplitude changes of the two shaking systems were measured, and compared with the standard, the amplitude of adding only the antigen The change values were compared to calculate the concentration of the antigen abamectin. The minimum detection limit of this method can reach 2.1*10 -8 mol/L.
实施例4 Example 4
本实施例采用链霉亲和素(streptavidin,SA)生物素法测定人抗肿瘤因子,将抗肿瘤因子抗体吸附在固相载体表面,加入待测样品,温育,洗涤,加入标记了生物素的抗人Ig,温育,洗涤,加入用碱性磷酸酯酶(ALP)标记后的链霉亲和素,温育,洗涤,加入磷酸苯酚酯为催化反应的底物,经催化水解后,底物磷酸苯酚酯水解生成了能使B-Z化学振荡体系改变的苯酚,将反应产物加入到NaBrO4-苹果酸-[NiL](ClO4)2-H2SO4的流动体系中,在连续流动搅拌反应器(CSTR)中,利用分析物脉冲微扰技术(APP),向远离平衡态的振荡体系中以脉冲的方式注入酶联免疫反应的水解产物,水解产物引起化学振荡的周期变化可以作为人抗肿瘤因子定性定量分析的依据,周期的变化与人抗肿瘤因子浓度之间的定量关系可以描述为 delta T= A*log C +B , delta T 为化学振荡周期的变化,C为人抗肿瘤免疫因子的浓度。 In this example, streptavidin (streptavidin, SA) biotin method was used to measure human anti-tumor factor, the anti-tumor factor antibody was adsorbed on the surface of the solid phase carrier, the sample to be tested was added, incubated, washed, and labeled with biotin Anti-human Ig, incubated, washed, added streptavidin labeled with alkaline phosphatase (ALP), incubated, washed, added phosphate phenol ester as the substrate of the catalytic reaction, after catalytic hydrolysis, The hydrolysis of the substrate phenolic phosphate produces phenol that can change the BZ chemical oscillation system . In the Stirred Reactor (CSTR), using the analyte pulse perturbation technique (APP), the hydrolyzate of the enzyme-linked immunoreaction is injected into the oscillating system far away from the equilibrium state in a pulsed manner, and the periodic change of the chemical oscillation caused by the hydrolyzate can be used as The basis for the qualitative and quantitative analysis of human anti-tumor factors, the quantitative relationship between the change of cycle and the concentration of human anti-tumor factors can be described as delta T= A*log C +B, delta T is the change of chemical oscillation cycle, C is the human anti-tumor factor Concentration of immune factors.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110439079 CN102495207B (en) | 2011-12-26 | 2011-12-26 | High-sensitivity enzyme-linked immunoassay method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110439079 CN102495207B (en) | 2011-12-26 | 2011-12-26 | High-sensitivity enzyme-linked immunoassay method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102495207A CN102495207A (en) | 2012-06-13 |
CN102495207B true CN102495207B (en) | 2013-10-30 |
Family
ID=46187048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110439079 Expired - Fee Related CN102495207B (en) | 2011-12-26 | 2011-12-26 | High-sensitivity enzyme-linked immunoassay method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102495207B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104049005A (en) * | 2013-03-11 | 2014-09-17 | 安徽大学 | Detection method of phenol |
CN104089950B (en) * | 2014-07-16 | 2017-12-26 | 国家纳米科学中心 | A kind of method and its application of Visual retrieval antigen-antibody reaction |
CN106020262B (en) * | 2016-07-04 | 2017-12-05 | 西北工业大学 | Strengthen the mixing regulation and control method of chemical oscillating reaction process |
CN106248951B (en) * | 2016-07-11 | 2018-03-06 | 福州市传染病医院 | A kind of detection galectin 4 fluorescence enzyme-linked immune analytic method |
CN107064487A (en) * | 2017-02-14 | 2017-08-18 | 安徽雷根生物技术有限公司 | A kind of graphene accelerates elisa technique |
CN109900689B (en) * | 2019-03-28 | 2021-12-10 | 复星诊断科技(长沙)有限公司 | Anti-interference membrane and liver function combined test strip |
CN112394166B (en) * | 2020-11-09 | 2024-06-25 | 广东希格生物科技有限公司 | Application of hexafluorophosphate in preparation of preparation for inhibiting ELISA reaction matrix effect |
CN114994329A (en) * | 2022-04-28 | 2022-09-02 | 杭州广科安德生物科技有限公司 | Method for detecting expression levels of p185 protein and p95 protein in tumor tissue |
CN114994194B (en) * | 2022-05-09 | 2024-04-09 | 广东安纳检测技术有限公司 | Method and device for measuring malonic acid in water |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101358955A (en) * | 2008-09-13 | 2009-02-04 | 西北师范大学 | A Method for Acquiring Frequency of Chemical Oscillation Reaction Signal |
JP2009276153A (en) * | 2008-05-13 | 2009-11-26 | Sumitomo Bakelite Co Ltd | Gastric cancer determination method |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010123949A1 (en) * | 2009-04-20 | 2010-10-28 | Arbor Vita Corporation | Methods of detecting hpv strains using synergistic antibodies |
-
2011
- 2011-12-26 CN CN 201110439079 patent/CN102495207B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009276153A (en) * | 2008-05-13 | 2009-11-26 | Sumitomo Bakelite Co Ltd | Gastric cancer determination method |
CN101358955A (en) * | 2008-09-13 | 2009-02-04 | 西北师范大学 | A Method for Acquiring Frequency of Chemical Oscillation Reaction Signal |
Non-Patent Citations (14)
Title |
---|
B-Z化学振荡反应在农药残留检测中的应用;李玉双;《工程科技辑》;20100104;全文 * |
Dual Control Mechanism in a Belousov-Zhabotinskii (B-Z) Oscillator with Glucose and Oxalic Acid as a Double Substrate;R. P. Rastogi et al;《J. Phys. Chem. A》;20051231;第109卷;4562-4567 * |
R. P. Rastogi et al.Dual Control Mechanism in a Belousov-Zhabotinskii (B-Z) Oscillator with Glucose and Oxalic Acid as a Double Substrate.《J. Phys. Chem. A》.2005,第109卷4562-4567. |
以2-磷酸抗坏血酸酯为底物检测碱性磷酸酯酶的微分脉冲伏安法;孙伟等;《分析测试学报》;20020930;第21卷(第5期);13-15 * |
以Mn2+催化精氨酸为底物的化学振荡反应研究;原春兰登;《西南师范大学学报》;19930930;第18卷(第3期);326-330 * |
刘海燕等.化学振荡的问接扰动法测定磷酸苯酯.《安徽大学学报》.2011,第35卷(第11期),85-90. |
化学振荡的问接扰动法测定磷酸苯酯;刘海燕等;《安徽大学学报》;20110131;第35卷(第11期);85-90 * |
原春兰登.以Mn2+催化精氨酸为底物的化学振荡反应研究.《西南师范大学学报》.1993,第18卷(第3期),326-330. |
四氮杂大环铜配合物催化的化学振荡反应分析测定氨基酸;沈慧;《工程科技辑》;20100203;全文 * |
孙伟等.以2-磷酸抗坏血酸酯为底物检测碱性磷酸酯酶的微分脉冲伏安法.《分析测试学报》.2002,第21卷(第5期),13-15. |
孙伟等.磷酸苯酯-碱性磷酸酯酶伏安酶联免疫分析新体系的研究.《分析试验室》.2002,第21卷(第1期),13-15. |
李玉双.B-Z化学振荡反应在农药残留检测中的应用.《工程科技辑》.2010,全文. |
沈慧.四氮杂大环铜配合物催化的化学振荡反应分析测定氨基酸.《工程科技辑》.2010,全文. |
磷酸苯酯-碱性磷酸酯酶伏安酶联免疫分析新体系的研究;孙伟等;《分析试验室》;20020131;第21卷(第1期);13-15 * |
Also Published As
Publication number | Publication date |
---|---|
CN102495207A (en) | 2012-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102495207B (en) | High-sensitivity enzyme-linked immunoassay method | |
US4999284A (en) | Enzymatically amplified piezoelectric specific binding assay | |
Tang et al. | Hemin/G-quadruplex-based DNAzyme concatamers as electrocatalysts and biolabels for amplified electrochemical immunosensing of IgG1 | |
Negahdary et al. | An aptamer-based biosensor for troponin I detection in diagnosis of myocardial infarction | |
Larou et al. | High throughput cellular biosensor for the ultra-sensitive, ultra-rapid detection of aflatoxin M1 | |
Ma et al. | Aptamer-based portable biosensor for platelet-derived growth factor-BB (PDGF-BB) with personal glucose meter readout | |
Hervás et al. | Electrochemical immunoassay using magnetic beads for the determination of zearalenone in baby food: An anticipated analytical tool for food safety | |
Liu et al. | Construction of an impedimetric immunosensor for label-free detecting carbofuran residual in agricultural and environmental samples | |
Long et al. | Sensitive and rapid chemiluminescence enzyme immunoassay for microcystin-LR in water samples | |
Feng et al. | Electrochemical immunosensor with aptamer-based enzymatic amplification | |
Ouyang et al. | Novel chemiluminescent immunochromatographic assay using a dual-readout signal probe for multiplexed detection of pesticide residues | |
Guan et al. | Prussian blue modified amperometric FIA biosensor: one-step immunoassay for α-fetoprotein | |
Li et al. | An aptasensor for the detection of ampicillin in milk using a personal glucose meter | |
CN106841603A (en) | A kind of method of utilization blood glucose meter quantitative determination AFB1 | |
Kim et al. | Electrochemical biosensor using direct electron transfer and an antibody–aptamer hybrid sandwich for target detection in complex biological samples | |
Su et al. | Serological determination of Helicobacter pylori infection using sandwiched and enzymatically amplified piezoelectric biosensor | |
CN105353116B (en) | A kind of method and its application that immunoassay is carried out based on hydrogen peroxide test strips | |
Wang et al. | Emission onset time-adjustable chemiluminescent gold nanoparticles with ultrastrong emission for smartphone-based immunoassay of severe acute respiratory syndrome coronavirus 2 antigen | |
Tang et al. | Homogeneous electrochemical immunoassay of aflatoxin B 1 in foodstuff using proximity-hybridization-induced omega-like DNA junctions and exonuclease III-triggered isothermal cycling signal amplification | |
Medyantseva et al. | Immunosensors in biology and medicine: analytical capabilities, problems, and prospects | |
Chung et al. | Sequential analysis of multiple analytes using a surface plasmon resonance (SPR) biosensor | |
CN114854828A (en) | Nucleic acid probe for detecting OTA, blood glucose meter biosensor, preparation method, detection method and use | |
He et al. | Enhanced performance of a surface plasmon resonance-based immunosensor for the detection of glycocholic acid | |
von Lode et al. | One-step quantitative thyrotropin assay for the detection of hypothyroidism in point-of-care conditions | |
Liu et al. | Renewable amperometric immunosensor for complement 3 (C3) assay in human serum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131030 Termination date: 20151226 |
|
EXPY | Termination of patent right or utility model |